These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38622716)

  • 21. A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma.
    Zhang Y; Wang Y; Chen J; Xia Y; Huang Y
    Front Immunol; 2023; 14():1183230. PubMed ID: 37671155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
    Uddin MN; Akter R; Li M; Abdelrahman Z
    Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
    Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
    J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma.
    Ren J; Wang A; Liu J; Yuan Q
    Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD.
    Zhao Z; Yin W; Peng X; Cai Q; He B; Shi S; Peng W; Tu G; Li Y; Li D; Tao Y; Peng M; Wang X; Yu F
    Front Immunol; 2022; 13():872387. PubMed ID: 35693786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The construction and analysis of ceRNA network and patterns of immune infiltration in lung adenocarcinoma.
    Li J; Liu W; Dong X; Dai Y; Chen S; Zhao E; Liu Y; Bao H
    BMC Cancer; 2021 Nov; 21(1):1228. PubMed ID: 34781924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama.
    Cai L; Hua H; Jiang X; Xu X; Bai H; Qian L; Duan J
    BMC Cancer; 2023 Jun; 23(1):514. PubMed ID: 37280528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms.
    Zhang N; Zhang H; Liu Z; Dai Z; Wu W; Zhou R; Li S; Wang Z; Liang X; Wen J; Zhang X; Zhang B; Ouyang S; Zhang J; Luo P; Li X; Cheng Q
    Cell Prolif; 2023 Apr; 56(4):e13409. PubMed ID: 36822595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma.
    Chen Z; Huang Y; Hu Z; Zhao M; Li M; Bi G; Zheng Y; Liang J; Lu T; Jiang W; Xu S; Zhan C; Xi J; Wang Q; Tan L
    Clin Transl Med; 2021 Mar; 11(3):e350. PubMed ID: 33783985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
    Xu S; Zhou J; Liu K; Chen Z; He Z
    Biomed Res Int; 2020; 2020():9124792. PubMed ID: 33224985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the fatty acid metabolism-related genes in lung adenocarcinoma to guide clinical therapy.
    Huang G; Zhang J; Gong L; Wang X; Zhang B; Liu D
    BMC Pulm Med; 2022 Dec; 22(1):486. PubMed ID: 36564744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma.
    Wang N; Chai M; Zhu L; Liu J; Yu C; Huang X
    Front Immunol; 2023; 14():1070953. PubMed ID: 37334367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell and Bulk RNA-Seq reveal angiogenic heterogeneity and microenvironmental features to evaluate prognosis and therapeutic response in lung adenocarcinoma.
    Tang L; Chen Z; Yang J; Li Q; Wang S; Mo T; Zeng W; Ding H; Pan S
    Front Immunol; 2024; 15():1352893. PubMed ID: 38390340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma.
    Wang H; Lu X; Chen J
    BMC Med Genomics; 2022 Dec; 15(1):254. PubMed ID: 36503492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
    Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
    J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma.
    Liang JX; Chen Q; Gao W; Chen D; Qian XY; Bi JQ; Lin XC; Han BB; Liu JS
    BMC Bioinformatics; 2022 Dec; 23(1):562. PubMed ID: 36575396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
    Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
    Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
    Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
    Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
    Shi R; Bao X; Unger K; Sun J; Lu S; Manapov F; Wang X; Belka C; Li M
    Theranostics; 2021; 11(10):5061-5076. PubMed ID: 33754044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.